Related Experiment Video
Updated: Jun 28, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardio-renal anemia syndrome
G Efstratiadis1, D Konstantinou, I Chytas
1Nephrology Department, Aristotle University of Thessaloniki Hippokratio Hospital, Thessaloniki. efstrati@med.auth.gr
Hippokratia
|October 17, 2008
Summary
Chronic heart failure, chronic kidney insufficiency, and anemia interact in a vicious cycle, known as cardio-renal anemia syndrome. Understanding this syndrome
Area of Science:
- Cardiology
- Nephrology
- Hematology
Background:
- Chronic heart failure (CHF), chronic kidney insufficiency (CKI), and anemia often coexist.
- These conditions create a detrimental cycle, worsening overall patient health.
- The interplay between CHF, CKI, and anemia is termed cardio-renal anemia syndrome.
Purpose of the Study:
- To analyze the complex pathophysiological mechanisms of cardio-renal anemia syndrome.
- To highlight key areas of clinical investigation for this emerging syndrome.
- To discuss therapeutic strategies for managing anemia within this syndrome.
Main Methods:
- Review and analysis of existing literature on the cardio-renal anemia syndrome.
- Speculative analysis of pathophysiological mechanisms.
- Examination of current data on anemia treatment in affected patients.
Main Results:
- The cardio-renal anemia syndrome involves a complex interplay where each condition exacerbates the others.
- Significant deterioration in cardiac and renal function is observed.
- Anemia is a key component, worsening with the progression of heart and kidney disease.
Conclusions:
- Cardio-renal anemia syndrome is a significant and growing area of clinical research.
- Understanding the shared pathophysiology is crucial for effective management.
- Anemia treatment is an important therapeutic consideration for patients with this syndrome.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:29Renal Regulation of Acid-Base Balance
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
01:20Renal Corpuscle
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...